Abstract:AbstractBackgroundOlfactory dysfunction has been reported for its association with cognitive impairment and incident dementia. However, the underlying role of neurodegeneration in this relationship is not fully understood.MethodThis prospective cohort study included participants from the Shanghai Aging Study (SAS) who were 60 years or older and diagnosed as dementia‐free at baseline and completed at least one follow‐up interview between 2010 and 2022. At baseline, olfactory identification function was assessed by the 12‐item Sniffin’ Sticks Smell test (SSST‐12). Olfactory dysfunction was defined as SSST‐12 < 7, 6, and 5 in three age groups of participants with (age < 70, 70 ≤ age < 80, and age ≥ 80), respectively, according to previously reported normative data of olfaction in the SAS. Baseline blood Neurofilament Light Chain (NfL) was quantified using the ultra‐sensitive Single Molecular Array technology (Quanterix), and dichotomized into low and high levels according to the median concentration. Multiple cognitive function assessments were administered by the Mini‐mental State Examination (MMSE) at baseline and follow‐ups. We used the linear mixed‐effect model to fit the MMSE trajectories in participants with and without olfactory dysfunction adjusting for baseline age, sex, education year, smoking, and APOE ε4, with person‐specific MMSE intercept and slope. Stratified analysis was conducted in participants with low and high NfL.ResultAmong 1125 participants included in this study, 296 were defined as having olfactory dysfunction at baseline. Less education, higher proportion of APOE ε4 allele, and lower baseline and follow‐up MMSE scores were observed in participants with olfactory dysfunction (Table 1). During the median 9.4 years follow‐up, participants with olfactory dysfunction at baseline evidenced a faster MMSE decline compared with those without olfactory dysfunction (b [95% CI]: ‐0.08 [‐0.15, ‐0.02], P = 0.02) (Figure 1). Such association remained statistically significant (‐0.18 [‐0.31, ‐0.06], P = 0.005) in the subgroup with high NfL, but not in the subgroup with low NfL (0.004 [‐0.07, 0.07], P = 0.92) (Figure 2).ConclusionBlood NfL may modify the association of olfactory dysfunction with long‐term cognitive decline in community‐dwelling older adults. In individuals with high potential neurodegeneration, olfactory dysfunction may be an independent indicator of future cognitive deterioration.

Serum neurofilament light chain and cognition decline in US elderly: A cross-sectional study

The association between NfL and Cognitive Functioning in older adults diagnosed diabetes: a cross-sectional analysis from NHANES

Association between serum neurofilament light chains (sNfL) and neurologic disorders in a representative sample of US adults: a cross-sectional study

The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer's Disease Continuum: A Systematic Review and Meta-Analysis

Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer's Disease Continuum

Serum Neurofilament Dynamics Predicts Cognitive Progression in De Novo Parkinson's Disease.

Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal Study

Association of Plasma Neurofilament Light With Small Vessel Disease Burden in Nondemented Elderly: A Longitudinal Study.

Plasma neurofilament light chain in relation to 10-year change in cognition and neuroimaging markers: a population-based study

Associations of plasma neurofilament light chain with cognition and neuroimaging measures in community-dwelling early old age men

Plasma Neurofilament Light And Future Declines In Cognition And Function In Alzheimer'S Disease In The Fit-Ad Trial

Predictive value of serum neurofilament light chain for cognitive impairment in Parkinson's disease

Neurofilament Light Chain as a Biomarker of Global Cognition in Individuals With Possible Vascular Mild Cognitive Impairment

Elevated plasma neurofilament light was associated with multi-modal neuroimaging features in Alzheimer's disease signature regions and predicted future tau deposition

Neurofilament Light Chain As a Potential Biomarker in Plasma for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and a Meta-Analysis.

Neurofilament Light Chain Modifies the Association of Olfactory Dysfunction with Cognitive Decline: a 12‐year Follow‐up of the Shanghai Aging Study

Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment

Non‐neurological factors associated with serum neurofilament levels in the United States population

Association between plasma neurofilament light chain levels and cognitive function in patients with Parkinson's disease

Circulating Neurofilament Light Predicts Cognitive Decline in Patients With Post-stroke Subjective Cognitive Impairment

Association of frailty and serum neurofilament light chain levels: the mediating role of estimated glomerular filtration rate